TickerFacts.

Company research / CYDY

CytoDyn Inc. (CYDY)

Build a valuation ↗↓ Download CSV

CIK 0001175680 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends May 31

For the year ended 2023-05-31, CytoDyn Inc. reported revenue of $0. Revenue fell 100.0% from the prior annual period.

Key ratios (year ended 2023-05-31)

-100.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-K · 2026-08-31

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2026-05-312025-05-312024-05-312023-05-312022-05-312021-05-312020-05-312019-05-312018-05-312017-05-31
Revenue———$0$266.0K$0————
Cost of Revenue————$53.0K—————
Gross Profit————$213.0K—————
Operating Income-$38.58M$9.66M-$18.06M-$40.58M-$145.40M-$104.60M-$74.65M-$55.85M-$45.92M-$27.33M
Net Income-$42.70M$3.75M-$49.84M-$79.82M-$210.82M-$176.47M-$139.94M-$56.19M-$50.15M-$25.76M
EPS (Diluted)$-0.03$0.00$-0.05$-0.10$-0.31$-0.30$-0.33———
Total Assets$13.97M$18.05M$11.14M$11.29M$29.18M$132.08M$50.51M$20.87M$4.90M$8.06M
Total Liabilities$123.69M$114.09M$127.89M$120.79M$123.58M$153.10M$52.99M$29.79M$18.06M$9.16M
Shareholders' Equity-$109.72M-$96.04M-$116.76M-$109.50M-$94.40M-$21.02M-$2.48M-$8.91M-$13.16M-$1.10M
Cash & Equivalents$11.85M$11.90M$3.11M$2.54M$4.23M$33.94M$14.28M$2.61M$1.23M$1.78M
Operating Cash Flow-$17.25M-$8.77M-$10.98M-$25.11M-$77.72M-$117.57M-$68.80M-$50.47M-$29.90M-$26.73M
Capital Expenditures—————$122.0K$41.0K$26.0K$0$11.1K
Shares Outstanding1.37B1.25B1.06B918.61M719.59M625.68M518.98M329.40M216.72M149.47M
Weighted Average Diluted Shares1.29B1.24B969.51M836.53M676.90M587.59M421.08M———
EPS (Basic)$-0.03$0.00$-0.05$-0.10$-0.31$-0.30$-0.33———